Jin Y, Wang Z, He D, Zhu Y, Chen X, Cao K. Identification of novel subtypes based on ssGSEA in immune-related prognostic signature for tongue squamous cell carcinoma. Cancer Med. 2021;10(23):8693–707.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Huang L, Luo EL, Xie J, Gan RH, Ding LC, Su BH, Zhao Y, Lin LS, Zheng DL. FZD2 regulates cell proliferation and invasion in tongue squamous cell carcinoma. Int J Biol Sci. 2019;15(11):2330–9.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Tsvetkova D, Ivanova S. Application of approved cisplatin derivatives in combination therapy against different Cancer diseases. Molecules. 2022;27(8):2466.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Domingo IK, Latif A, Bhavsar AP. Pro-inflammatory signalling PRRopels Cisplatin-Induced toxicity. Int J Mol Sci. 2022;23(13):7227.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ghosh S, Cisplatin. The first metal based anticancer drug. Bioorg Chem. 2019;88:102925.

Article  CAS  PubMed  Google Scholar 

Wang J, Chen Y, Xiang F, Li M, Li H, Chi J, Ren K. Suppression of TGF-β1 enhances chemosensitivity of cisplatin-resistant lung cancer cells through the inhibition of drug-resistant proteins. Artif Cells Nanomed Biotechnol. 2018;46(7):1505–12.

Article  CAS  PubMed  Google Scholar 

Kim SK, Park JA, Zhang D, Cho SH, Yi H, Cho SM, Chang BJ, et al. Sustainability of CD24 expression, cell proliferation and migration, cisplatin-resistance, and caspase-3 expression during mesenchymal-epithelial transition induced by the removal of TGF-β1 in A549 lung cancer cells. Oncol Lett. 2017;14(2):2410–6.

Article  PubMed  PubMed Central  Google Scholar 

Ashrafizadeh M, Zarrabi A, Hushmandi K, Kalantari M, Mohammadinejad R, Javaheri T, Sethi G. Association of the Epithelial-Mesenchymal Transition (EMT) with cisplatin resistance. Int J Mol Sci. 2020;21(11):4002.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Dasari S, Njiki S, Mbemi A, Yedjou CG, Tchounwou PB. Pharmacological effects of Cisplatin Combination with Natural products in Cancer Chemotherapy. Int J Mol Sci. 2022;23(3):1532.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Laslett LL, Jones G. Capsaicin for osteoarthritis pain. Prog Drug Res. 2014;68:277–91.

CAS  PubMed  Google Scholar 

Gašparini D, Ljubičić R, Mršić-Pelčić J. Capsaicin - potential solution for Chronic Pain Treatment. Psychiatr Danub. 2020;32:420–8.

PubMed  Google Scholar 

Friedman JR, Richbart SD, Merritt JC, Brown KC, Denning KL, Tirona MT, Valentovic MA, Miles SL, Dasgupta P. Capsaicinoids: multiple effects on angiogenesis, invasion and metastasis in human cancers. Biomed Pharmacother. 2019;118:109317.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wutka A, Palagani V, Barat S, Chen X, El Khatib M, et al. Correction: Capsaicin Treatment attenuates Cholangiocarcinoma Carcinogenesis. PLoS ONE. 2016;11(9):e0162673.

Article  PubMed  PubMed Central  Google Scholar 

Sugiyama Y, Nakazawa Y, Sakagami T, Kawata S, Nagai N, Yamamoto N, Funakoshi-Tago M, Tamura H. Capsaicin attenuates TGFβ2-induced epithelial-mesenchymal-transition in lens epithelial cells in vivo and in vitro. Exp Eye Res. 2021;213:108840.

Article  CAS  PubMed  Google Scholar 

Dai N, Ye R, He Q, Guo P, Chen H, Zhang Q. Capsaicin and Sorafenib combination treatment exerts synergistic anti–hepatocellular carcinoma activity by suppressing EGFR and PI3K/Akt/mTOR signaling. Oncol Rep. 2018;40(6):3235–48.

CAS  PubMed  PubMed Central  Google Scholar 

Zheng J, Zhou Y, Li Y, Xu DP, Li S, Li HB. Spices for Prevention and Treatment of Cancers. Nutrients. 2016;12(8):495.

Article  Google Scholar 

Kim BN, Ahn DH, Kang N, Yeo CD, Kim YK, Lee KY, Kim TJ, Lee SH, Park MS, et al. TGF-β induced EMT and stemness characteristics are associated with epigenetic regulation in lung cancer. Sci Rep. 2020;30(1):10597.

Article  Google Scholar 

Deng L, Zou J, Su Y, Wang M, Zhao L. Resveratrol inhibits TGF-β1-induced EMT in gastric cancer cells through Hippo-YAP signaling pathway. Clin Transl Oncol. 2022;24(11):2210–21.

Article  CAS  PubMed  Google Scholar 

Huang Y, Hong W, Wei X. The molecular mechanisms and therapeutic strategies of EMT in tumor progression and metastasis. J Hematol Oncol. 2022;15(1):129.

Article  PubMed  PubMed Central  Google Scholar 

Ranjan A, Ramachandran S, Gupta N, Kaushik I, Wright S, Srivastava S, Das H, Srivastava S, Prasad S, et al. Role of Phytochemicals in Cancer Prevention. Int J Mol Sci. 2019;20(20):4981.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Peng D, Fu M, Wang M, Wei Y, Wei X. Targeting TGF-β signal transduction for fibrosis and cancer therapy. Mol Cancer. 2022;21(1):104.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Brabletz S, Schuhwerk H, Brabletz T, Stemmler MP. Dynamic EMT: a multi-tool for tumor progression. EMBO J. 2021;40(18):e108647.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Yamamoto D, Kayamori K, Sakamoto K, Tsuchiya M, Ikeda T, Harada H, Yoda T, Watabe T, Hara-Yokoyama M. Intracellular claudin-1 at the invasive front of tongue squamous cell carcinoma is associated with lymph node metastasis. Cancer Sci. 2020;111(2):700–12.

Article  CAS  PubMed  Google Scholar 

Eftang LL, Esbensen Y, Tannæs TM, Blom GP, Bukholm IR, Bukholm G. Up-regulation of CLDN1 in gastric cancer is correlated with reduced survival. BMC Cancer. 2013;13:586.

Article  PubMed  PubMed Central  Google Scholar 

Luan N, Chen Y, Li Q, Mu Y, Zhou Q, Ye X, Deng Q, Ling L, Wang J, et al. TRF-20-M0NK5Y93 suppresses the metastasis of colon cancer cells by impairing the epithelial-to-mesenchymal transition through targeting Claudin-1. Am J Transl Res. 2021;13(1):124–42.

CAS  PubMed  PubMed Central  Google Scholar 

Bhat AA, Syed N, Therachiyil L, Nisar S, Hashem S, Macha MA, Yadav SK, Krishnankutty R, et al. Claudin-1, a double-edged Sword in Cancer. Int J Mol Sci. 2020;21(2):569.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Gyulai M, Harko T, Fabian K, Karsko L, Agocs L, Szigeti B, Fillinger J, Szallasi Z, Pipek O, Moldvay J. Claudin expression in pulmonary adenoid cystic carcinoma and mucoepidermoid carcinoma. Pathol Oncol Res. 2023;29:1611328.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Primeaux M, Liu X, Gowrikumar S, Fatima I, Fisher KW, Bastola D, Vecchio AJ, Singh AB, Dhawan P. Claudin-1 interacts with EPHA2 to promote cancer stemness and chemoresistance in colorectal cancer. Cancer Lett. 2023;579:216479.

Article  CAS  PubMed  Google Scholar 

Mahati S, Xiao L, Yang Y, Mao R, Bao Y. miR-29a suppresses growth and migration of hepatocellular carcinoma by regulating CLDN1. Biochem Biophys Res Commun. 2017;486(3):732–7.

Article  CAS  PubMed  Google Scholar 

Wu Q, Qiu Y, Guo J, Yuan Z, Yang Y, Zhu Q, Zhang Z, Guo J, Wu Y, Zhang J, Huang D, Tu K, Hu X. USP40 promotes hepatocellular carcinoma cell proliferation, migration and stemness by deubiquitinating and stabilizing Claudin1. Biol Direct. 2024;2(1):1